Pathogenesis of microbial keratitis.
暂无分享,去创建一个
Naveed Ahmed Khan | R. Siddiqui | N. Khan | Ruqaiyyah Siddiqui | Sahreena Lakhundi | Sahreena Lakhundi
[1] H. Wösten,et al. Fungal hydrophobins in medical and technical applications , 2001, Applied Microbiology and Biotechnology.
[2] M. Amiri,et al. Contact lens disinfecting solutions antibacterial efficacy: comparison between clinical isolates and the standard ISO ATCC strains of Pseudomonas aeruginosa and Staphylococcus aureus , 2012, Eye.
[3] T. O'brien,et al. Management of bacterial keratitis: beyond exorcism towards consideration of organism and host factors , 2003, Eye.
[4] Patricia Adams. HOST , 2013, Creativity & Cognition.
[5] A. Kreger,et al. Purification and Characterization of a Serratia marcescens Metalloprotease , 1979, Infection and immunity.
[6] P. Thomas. Mycotic keratitis--an underestimated mycosis. , 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[7] Dan B. Jones,et al. Clinical characteristics and outcome of Candida keratitis. , 2007, American journal of ophthalmology.
[8] E. Cohen,et al. Clear corneal wound infection after phacoemulsification. , 2001, Archives of ophthalmology.
[9] G. Rajam,et al. RETRACTED: Pneumococcal Surface Adhesin A (PsaA): A Review , 2008, Critical reviews in microbiology.
[10] P. Thomas. Current Perspectives on Ophthalmic Mycoses , 2003, Clinical Microbiology Reviews.
[11] Hyndiuk Ra. Experimental Pseudomonas keratitis. , 1981 .
[12] L. Peterson,et al. Contribution of Topoisomerase IV and DNA Gyrase Mutations in Streptococcus pneumoniae to Resistance to Novel Fluoroquinolones , 1999, Antimicrobial Agents and Chemotherapy.
[13] R. L. Font,et al. Acanthamoeba keratitis possibly acquired from a hot tub. , 1984, Archives of ophthalmology.
[14] P. Geraldine,et al. Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production , 2010, Molecular vision.
[15] M. I. Tadros,et al. Positively Charged Polymeric Nanoparticle Reservoirs of Terbinafine Hydrochloride: Preclinical Implications for Controlled Drug Delivery in the Aqueous Humor of Rabbits , 2013, AAPS PharmSciTech.
[16] S. H. Hernández-Da Mota,et al. Ultraviolet-A Light and Riboflavin Therapy for Acanthamoeba Keratitis: A Case Report , 2011, Case Reports in Ophthalmology.
[17] M. Serra,et al. Mode of action of beta-barrel pore-forming toxins of the staphylococcal alpha-hemolysin family. , 2001, Toxicon : official journal of the International Society on Toxinology.
[18] P. Padmanabhan,et al. Fluconazole in filamentous fungal keratitis. , 1997, Cornea.
[19] R. E. Smith,et al. Epidemiology of microbial keratitis in southern California. A multivariate analysis. , 1987, Ophthalmology.
[20] G. Rao,et al. Enzymatic, clinical and histologic evaluation of corneal tissues in experimental fungal keratitis in rabbits. , 2001, Experimental eye research.
[21] J. Niederkorn,et al. The pathophysiology of Acanthamoeba keratitis. , 2006, Trends in parasitology.
[22] J. Alió,et al. Microbial keratitis after intrastromal corneal ring segment implantation. , 2010, Journal of refractive surgery.
[23] A. Maden,et al. Microbial keratitis in West Anatolia, Turkey: a retrospective review , 2007, International Ophthalmology.
[24] D. Jefferson,et al. Role of Carbohydrate-mediated Adherence in Cytopathogenic Mechanisms of Acanthamoeba * , 1998, The Journal of Biological Chemistry.
[25] Shirley Lam,et al. Efficacy of Contact Lens Multipurpose Solutions Against Serratia Marcescens , 2007, Optometry and vision science : official publication of the American Academy of Optometry.
[26] N. Khan. Pathogenicity, Morphology, and Differentiation of Acanthamoeba , 2001, Current Microbiology.
[27] M. Marquart,et al. Infectious Keratitis: Secreted Bacterial Proteins That Mediate Corneal Damage , 2013, Journal of ophthalmology.
[28] N. Khan,et al. The role of proteases in the differentiation of Acanthamoeba castellanii. , 2008, FEMS microbiology letters.
[29] S. Kilvington,et al. Acanthamoeba keratitis: diagnosis and treatment update 2009. , 2009, American journal of ophthalmology.
[30] J. Dart,et al. Cataract as a complication of severe microbial keratitis , 1992, Eye.
[31] P. Thomas,et al. Mycotic keratitis: epidemiology, diagnosis and management. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[32] Dina Fathalla,et al. A New Long-acting Liposomal Topical Antifungal Formula: Human Clinical Study , 2012, Cornea.
[33] J. McCulley,et al. In vitro and in vivo tumoricidal properties of a pathogenic/free-living amoeba. , 1993, Cancer letters.
[34] J. Jonckheere. Ecology of Acanthamoeba , 1991 .
[35] S. Romero-Steiner,et al. Inhibition of Pneumococcal Adherence to Human Nasopharyngeal Epithelial Cells by Anti-PsaA Antibodies , 2003, Clinical Diagnostic Laboratory Immunology.
[36] J. Zhao,et al. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. , 2008, American journal of ophthalmology.
[37] P. Andrew,et al. Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea. , 1995, Current eye research.
[38] R. H. Rosa,et al. The changing spectrum of fungal keratitis in south Florida. , 1994, Ophthalmology.
[39] Lu-tan Zhou,et al. In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi. , 2013, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[40] Scott D. Smith,et al. Epidemiology of ulcerative keratitis in Northern California. , 2010, Archives of ophthalmology.
[41] E. Bateman,et al. Cloning and Characterization of a Novel Mannose-binding Protein of Acanthamoeba* , 2004, Journal of Biological Chemistry.
[42] F. Schuster,et al. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. , 2007, FEMS immunology and medical microbiology.
[43] E. Hadaś,et al. Proteolytic enzymes of pathogenic and non-pathogenic strains of Acanthamoeba spp. , 1993, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.
[44] D. Glidden,et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. , 2012, Investigative ophthalmology & visual science.
[45] R. Vijayvargia,et al. Caveolin-1 binding motif of α-hemolysin: its role in stability and pore formation , 2004 .
[46] V. Jhanji,et al. Riboflavin/ultravoilet light-mediated crosslinking for fungal keratitis , 2013, British Journal of Ophthalmology.
[47] Caveolin-1 binding motif of alpha-hemolysin: its role in stability and pore formation. , 2004, Biochemical and biophysical research communications.
[48] G. Cabral,et al. Acanthamoeba spp. as Agents of Disease in Humans , 2003, Clinical Microbiology Reviews.
[49] J. Snyder,et al. Antibacterial effect of cyanoacrylate glue. , 1983, Archives of ophthalmology.
[50] D. Seal,et al. Drug resistance and Acanthamoeba Keratitis: The quest for alternative antiprotozoal chemotherapy , 1994, Eye.
[51] H. Saibil,et al. Subunit organisation and symmetry of pore‐forming, oligomeric pneumolysin , 1995, FEBS letters.
[52] C. Kaufmann,et al. Corneal Cross-Linking as Supplementary Treatment Option in Melting Keratitis: A Case Series , 2012, Klinische Monatsblätter für Augenheilkunde.
[53] C. Saturnino,et al. Amoebicidal efficiencies of various diamidines against two strains of Acanthamoeba polyphaga , 1995, Antimicrobial agents and chemotherapy.
[54] A. Gravet,et al. Characterization of a novel structural member, LukE‐LukD, of the bi‐component staphylococcal leucotoxins family , 1998, FEBS letters.
[55] H. Maeda,et al. The serratial 56K protease as a major pathogenic factor in serratial keratitis. Clinical and experimental study. , 1985, Ophthalmology.
[56] Naveed Ahmed Khan,et al. Biology and pathogenesis of Acanthamoeba , 2012, Parasites & Vectors.
[57] N. Sharma,et al. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. , 2008, American journal of ophthalmology.
[58] A. Steele,et al. The role of penetrating keratoplasty in the management of microbial keratitis , 1991, Eye.
[59] T. Lifshitz,et al. Bacterial keratitis after laser subepithelial keratectomy. , 2005, Journal of refractive surgery.
[60] S. Kaur,et al. Assembly of α-hemolysin on A431 cells leads to clustering of Caveolin-1 , 2004 .
[61] Curtis N. James,et al. Activation of human complement by the pneumococcal toxin pneumolysin , 1984, Infection and immunity.
[62] D. Jones,et al. Decision-making in the management of microbial keratitis. , 1981, Ophthalmology.
[63] G. Pier,et al. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa , 1996, Infection and immunity.
[64] P. Parment. The role of Serratia marcescens in soft contact lens associated ocular infections. A review. , 2009, Acta ophthalmologica Scandinavica.
[65] L. Hazlett,et al. Corneal epithelial glycoproteins exhibit Pseudomonas aeruginosa pilus binding activity. , 1992, Investigative ophthalmology & visual science.
[66] Wei Chen,et al. Acanthamoeba keratitis: clinical characteristics and management. , 2006, Ophthalmology.
[67] Helen R. Saibil,et al. Structural Basis of Pore Formation by the Bacterial Toxin Pneumolysin , 2005, Cell.
[68] G. Johnson,et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis , 2002, The British journal of ophthalmology.
[69] H. D. Cavanagh,et al. Tear IgA and Serum IgG Antibodies Against Acanthamoeba in Patients With Acanthamoeba Keratitis , 2001, Cornea.
[70] A. Slomovic,et al. Microbial etiology and predisposing factors among patients hospitalized for corneal ulceration. , 1995, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[71] E. Tacconelli,et al. National guidelines for decolonization of methicillin-resistant Staphylococcus aureus carriers: the implications of recent experience in the Netherlands. , 2011, The Journal of antimicrobial chemotherapy.
[72] M. Willcox,et al. Factors influencing bacterial adhesion to contact lenses , 2012, Molecular vision.
[73] L. Hazlett,et al. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases. , 1986, Investigative ophthalmology & visual science.
[74] David J. Evans,et al. Traversal of multilayered corneal epithelia by cytotoxic Pseudomonas aeruginosa requires the phospholipase domain of exoU. , 2012, Investigative ophthalmology & visual science.
[75] J. Niederkorn,et al. Effects of mannose on Acanthamoeba castellanii proliferation and cytolytic ability to corneal epithelial cells. , 2003, Investigative ophthalmology & visual science.
[76] M. Busin,et al. Sustained gentamicin release by presoaked medicated bandage contact lenses. , 1988, Ophthalmology.
[77] J. A. Hobden,et al. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. , 1998, Investigative ophthalmology & visual science.
[78] M. Hostetter,et al. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces , 1994, Clinical Microbiology Reviews.
[79] S. Chaurasia,et al. Microbial keratitis after LASIK. , 2010, Journal of refractive surgery.
[80] A. Kreger,et al. Characterization of rabbit corneal damage produced by Serratia keratitis and by a serratia protease , 1981, Infection and immunity.
[81] M. Zimmerman,et al. Bacterial keratitis after penetrating keratoplasty: incidence, microbiological profile, graft survival, and visual outcome. , 2007, Ophthalmology.
[82] K R Kenyon,et al. Microbiology of contact lens-related keratitis. , 1989, Cornea.
[83] T. Naduvilath,et al. Relationship between climate, disease severity, and causative organism for contact lens-associated microbial keratitis in Australia. , 2007, American journal of ophthalmology.
[84] J. Bouchara,et al. Laminin receptors on Candida albicans germ tubes , 1990, Infection and immunity.
[85] Raymond L. M. Wong,et al. New Treatments for Bacterial Keratitis , 2012, Journal of ophthalmology.
[86] J. Bouchara,et al. Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion , 1994, Infection and immunity.
[87] M. Srinivasan,et al. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. , 2007, Archives of ophthalmology.
[88] S. Natarajan,et al. Aspergillus-induced Malignant Glaucoma , 2007, Cornea.
[89] S. Twining,et al. Relationship between proteases and descemetocele formation in experimental Pseudomonas keratitis. , 1986, Current eye research.
[90] Dina Fathalla,et al. Liposomes as an ocular delivery system of fluconazole: in‐vitro studies , 2010, Acta ophthalmologica.
[91] M. Berman. Regulation of Corneal Fibroblast MMP-1 Collagenase Secretion by Plasmin , 1993, Cornea.
[92] N. Sharma,et al. Therapeutic keratoplasty for infectious keratitis: a review of the literature. , 2002, The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc.
[93] N. Khan,et al. Proteases as Markers for Differentiation of Pathogenic and Nonpathogenic Species ofAcanthamoeba , 2000, Journal of Clinical Microbiology.
[94] I. Wang,et al. Therapeutic penetrating keratoplasty for microbial keratitis in Taiwan from 1987 to 2001. , 2004, American journal of ophthalmology.
[95] Y. Suenaga,et al. Invasion and survival of Fusarium solani in the dexamethasone-treated cornea of rabbits. , 1991, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[96] L. Hazlett. Analysis of ocular microbial adhesion. , 1995, Methods in enzymology.
[97] Y. Nishiyama,et al. Mechanism of Action of Efinaconazole, a Novel Triazole Antifungal Agent , 2013, Antimicrobial Agents and Chemotherapy.
[98] Eun-Kyung Moon,et al. Autophagy Inhibitors as a Potential Antiamoebic Treatment for Acanthamoeba Keratitis , 2015, Antimicrobial Agents and Chemotherapy.
[99] D. Frank,et al. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. , 1993, Investigative ophthalmology & visual science.
[100] A. Mahgoub. Review Article Acanthamoeba Keratitis , 2010 .
[101] P. A. Thomas,et al. Keratomycotic malignant glaucoma. , 1991, Indian journal of ophthalmology.
[102] S. Mirrett,et al. Topics in Clinical Microbiology , 1982, Infection Control.
[103] M. Gilmore,et al. Host-parasite interactions in Staphylococcus aureus keratitis. , 2002, DNA and cell biology.
[104] P. Wright,et al. Acanthamoeba keratitis successfully treated medically. , 1985, The British journal of ophthalmology.
[105] E. J. Miller,et al. Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase , 1986, Infection and immunity.
[106] A. Steele,et al. Amoebic infection of the eye. , 1974, Transactions of the ophthalmological societies of the United Kingdom.
[107] D. Sharma,et al. Microbial keratitis after corneal laser refractive surgery. , 2011, Future microbiology.
[108] K. Yoon,et al. Therapeutic Effect of Intracameral Amphotericin B Injection in the Treatment of Fungal Keratitis , 2007, Cornea.
[109] M. Marquart,et al. Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions. , 2009, Investigative ophthalmology & visual science.
[110] A. López-Arencibia,et al. Acanthamoeba keratitis: an emerging disease gathering importance worldwide? , 2013, Trends in parasitology.
[111] A. Galor,et al. Current Thoughts in Fungal Keratitis: Diagnosis and Treatment , 2013, Current Fungal Infection Reports.
[112] H Alizadeh,et al. The pathogenesis of Acanthamoeba keratitis. , 1999, Microbes and infection.
[113] M. Serra,et al. Mode of action of β-barrel pore-forming toxins of the staphylococcal α-hemolysin family , 2001 .
[114] T. Krunkosky,et al. Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas. , 2010, Veterinary ophthalmology.
[115] P. Asbell,et al. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005 , 2008, Journal of cataract and refractive surgery.
[116] J. Bouchara,et al. Adherence mechanisms in human pathogenic fungi. , 2008, Medical mycology.
[117] J. McCulley,et al. In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii. , 1990, Investigative ophthalmology & visual science.
[118] S. Blanke,et al. Characterization of a Cytotoxic Factor in Culture Filtrates of Serratia marcescens , 2002, Infection and Immunity.
[119] O. Lehmann,et al. Acanthamoeba keratitis: multicentre survey in England 1992–6 , 1998, The British journal of ophthalmology.
[120] Y. Tano,et al. Four Cases of Acanthamoeba Keratitis Treated With Phototherapeutic Keratectomy , 2010, Cornea.
[121] A. Behrens,et al. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. , 2011, Ophthalmology.
[122] U. Rehany,et al. The prevalence and risk factors for donor corneal button contamination and its association with ocular infection after transplantation. , 2004, Cornea.
[123] H. Thompson,et al. Collagen shield drug delivery: Therapeutic concentrations of tobramycin in the rabbit cornea and aqueous humor , 1988, Journal of cataract and refractive surgery.
[124] R. O'Callaghan,et al. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis , 1994, Infection and immunity.
[125] J. Latgé,et al. rodletless mutants of Aspergillus fumigatus , 1994, Infection and immunity.
[126] J. McCulley,et al. Apoptosis as a mechanism of cytolysis of tumor cells by a pathogenic free-living amoeba. , 1994, Infection and immunity.
[127] J. Niederkorn,et al. Pathogenic Acanthamoeba spp. Secrete a Mannose-Induced Cytolytic Protein That Correlates with the Ability To Cause Disease , 2003, Infection and Immunity.
[128] D. Krohn,et al. Liposomes in topical drug delivery. , 1982, Investigative ophthalmology & visual science.
[129] B. Nyström,et al. The efficacy of soft contact lens disinfection solutions against Serratia marcescens and Pseudomonas aeruginosa. , 2009, Acta ophthalmologica Scandinavica.
[130] Benjamin Clarke,et al. Advances in the Diagnosis and Treatment of Acanthamoeba Keratitis , 2012, Journal of ophthalmology.
[131] Hiba M. Salmo,et al. Development and Clinical Evaluation of Clotrimazole–β-Cyclodextrin Eyedrops for the Treatment of Fungal Keratitis , 2012, AAPS PharmSciTech.
[132] R. Scott,et al. Contact lens-related microbial keratitis in deployed British military personnel , 2010, British Journal of Ophthalmology.
[133] R. Ramakrishnan,et al. Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India , 2010, Indian journal of ophthalmology.
[134] C. Dohlman,et al. Prevention of corneal ulcers. , 1971, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.
[135] S. Tuft,et al. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. , 1997, Ophthalmology.
[136] M. Höök,et al. The Collagen-Binding Adhesin Is a Virulence Factor in Staphylococcus aureus Keratitis , 2000, Infection and Immunity.
[137] T. Liesegang. Conjunctival changes associated with glaucoma therapy: implications for the external disease consultant and the treatment of glaucoma. , 1998, Cornea.
[138] D. Brooks,et al. Profiles of matrix metalloproteinase activity in equine tear fluid during corneal healing in 10 horses with ulcerative keratitis. , 2004, Veterinary ophthalmology.
[139] S. Kilvington,et al. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. , 1994, Investigative ophthalmology & visual science.
[140] D. Tan,et al. Deep Lamellar Keratoplasty for Acanthamoeba Keratitis , 2007, Cornea.
[141] A. Ellison,et al. Therapeutic effects of heparin on Pseudomonas-induced corneal ulceration. , 1976, American journal of ophthalmology.
[142] M. Mabon,et al. Fungal Keratitis , 1998, International ophthalmology clinics.
[143] R. Fitzsimons,et al. Miconazole and ketoconazole as a satisfactory first-line treatment for keratomycosis. , 1986, American journal of ophthalmology.
[144] S. Hammerschmidt. Adherence molecules of pathogenic pneumococci. , 2006, Current opinion in microbiology.
[145] J. Tommassen,et al. Corneal Virulence of Pseudomonas aeruginosa Elastase B and Alkaline Protease Produced by Pseudomonas putida , 2007, Current eye research.
[146] J. Niederkorn,et al. Failure of Acanthamoeba castellanii to produce intraocular infections. , 2005, Investigative ophthalmology & visual science.
[147] Y. Zhang,et al. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival. , 2014, Investigative ophthalmology & visual science.
[148] S. Szmigielski,et al. Leukocidal toxins of staphylococci. , 1999, Zentralblatt fur Bakteriologie : international journal of medical microbiology.
[149] I. Gipson,et al. A Metalloproteinase Secreted by Streptococcus pneumoniae Removes Membrane Mucin MUC16 from the Epithelial Glycocalyx Barrier , 2012, PloS one.
[150] J. Mahanta,et al. Mycotic corneal ulcers in upper Assam , 2011, Indian journal of ophthalmology.
[151] Surjit Angra,et al. Topical Fluconazole Therapy of Candida Keratitis , 1996, Cornea.
[152] T. Seiler,et al. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. , 2003, American journal of ophthalmology.
[153] A. Kreger,et al. Cornea-damaging proteases of Serratia marcescens. , 1975, Investigative ophthalmology.
[154] Theo Seiler,et al. Increased resistance of crosslinked cornea against enzymatic digestion , 2004, Current eye research.
[155] J. Giaconi,et al. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. , 2004, American journal of ophthalmology.
[156] A. Ayadi,et al. Pathogenic free-living amoebae: epidemiology and clinical review. , 2012, Pathologie-biologie.
[157] Assembly of alpha-hemolysin on A431 cells leads to clustering of Caveolin-1. , 2004, Biochemical and biophysical research communications.
[158] S. Leal,et al. Host Response and Bacterial Virulence Factor Expression in Pseudomonas aeruginosa and Streptococcus pneumoniae Corneal Ulcers , 2013, PloS one.
[159] Weiyun Shi,et al. Spectrum of fungal keratitis in north China. , 2006, Ophthalmology.
[160] J. Blondeau. Fluoroquinolones: mechanism of action, classification, and development of resistance. , 2004, Survey of ophthalmology.
[161] J. McCulley,et al. The effect of therapeutic soft contact lenses on antibiotic delivery to the cornea. , 1985, Ophthalmology.
[162] Savitri Sharma,et al. Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: Experience of over a decade , 2009, Indian journal of ophthalmology.
[163] R. O'Callaghan,et al. Pseudomonas aeruginosa LasA protease and corneal infections , 2001, Current eye research.
[164] J. Gottsch,et al. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits. , 1988, Archives of ophthalmology.
[165] G. Sloop,et al. Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas. , 1997, Current eye research.
[166] J. Lissitzky,et al. Sialic acid-dependent recognition of laminin and fibrinogen by Aspergillus fumigatus conidia , 1997, Infection and immunity.
[167] B. Hube,et al. The role of secreted aspartyl proteinases in Candida albicans keratitis. , 2007, Investigative ophthalmology & visual science.
[168] G. Schultz,et al. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor. , 1996, Investigative ophthalmology & visual science.
[169] Yasunori Yamamoto,et al. An N-Linked Bidentate Phosphoramidite Ligand (N-Me-BIPAM) for Rhodium-Catalyzed Asymmetric 1,4-Addition of Arylboronic Acids to α,β-Unsaturated Ketones , 2012, Molecules.
[170] T. Seiler,et al. Techniques for stiffening the cornea. , 1999, Journal of refractive surgery.
[171] F. Stapleton,et al. Risk Factors and Causative Organisms in Microbial Keratitis , 2008, Cornea.
[172] D. Coster,et al. Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis. , 1987, The British journal of ophthalmology.
[173] R. Hay,et al. Sialic Acid-Dependent Recognition of Laminin byPenicillium marneffei Conidia , 1998, Infection and Immunity.
[174] P. Thomas,et al. Intrahyphal hyphae in corneal tissue from a case of keratitis due to Lasiodiplodia theobromae. , 1991, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[175] T. Lai,et al. Pediatric Ocular Surface Infections: A 5-year Review of Demographics, Clinical Features, Risk Factors, Microbiological Results, and Treatment , 2011, Cornea.
[176] J. Williamson,et al. In vitro destruction of nerve cell cultures by Acanthamoeba spp.: a transmission and scanning electron microscopy study. , 1996, The Journal of parasitology.
[177] E. Kessler,et al. Pseudomonas protease. Purification, partial characterization, and its effect on collagen, proteoglycan, and rabbit corneas. , 1977, Investigative ophthalmology & visual science.
[178] G. Rao,et al. Evaluation of agent and host factors in progression of mycotic keratitis: A histologic and microbiologic study of 167 corneal buttons. , 2002, Ophthalmology.
[179] K. Kwon-Chung,et al. HYP1, a hydrophobin gene from Aspergillus fumigatus, complements the rodletless phenotype in Aspergillus nidulans , 1994, Infection and immunity.
[180] E. Spoerl,et al. Induction of cross-links in corneal tissue. , 1998, Experimental eye research.
[181] K. Donaldson,et al. Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung. , 1996, Thorax.
[182] S. Rice,et al. Quorum-Sensing Regulation of Adhesion in Serratia marcescens MG1 Is Surface Dependent , 2007, Journal of bacteriology.
[183] F. Stapleton,et al. Contact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxis , 2012, Eye.
[184] M. R. Shah,et al. Photochemotherapeutic Strategy against Acanthamoeba Infections , 2015, Antimicrobial Agents and Chemotherapy.
[185] M. Marquart,et al. Ocular virulence of capsule-deficient streptococcus pneumoniae in a rabbit keratitis model. , 2005, Investigative ophthalmology & visual science.
[186] E. Edell,et al. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis. , 2010, American journal of ophthalmology.
[187] N. Gokhale. Medical management approach to infectious keratitis , 2008, Indian journal of ophthalmology.
[188] J. Niederkorn,et al. Role of Contact Lens Wear, Bacterial Flora, and Mannose-Induced Pathogenic Protease in the Pathogenesis of Amoebic Keratitis , 2005, Infection and Immunity.
[189] B. Kreiswirth,et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. , 1991, Ophthalmology.
[190] T. Foster,et al. Corneal pathogenesis of Staphylococcus aureus strain Newman. , 2002, Investigative ophthalmology & visual science.
[191] R. Kowalski,et al. Growth of acanthamoeba on human corneal epithelial cells and keratocytes in vitro. , 1991, Investigative ophthalmology & visual science.
[192] F. Price,et al. Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens , 2005, Journal of cataract and refractive surgery.
[193] P. Imwidthaya. Mycotic keratitis in Thailand. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[194] G. Nau,et al. A Serratia marcescens OxyR Homolog Mediates Surface Attachment and Biofilm Formation , 2007, Journal of bacteriology.
[195] W. Parks. Matrix metalloproteinases in repair , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[196] N. Khan. Pathogenesis of Acanthamoeba infections. , 2003, Microbial pathogenesis.
[197] R. Gerard,et al. Characterization of a plasminogen activator produced by Acanthamoeba castellanii. , 1995, Molecular and biochemical parasitology.
[198] K. Wojdyla,et al. Extracellular proteases of Aspergillus flavus. Fungal keratitis, proteases, and pathogenesis. , 1990, Diagnostic microbiology and infectious disease.
[199] A. Mallet,et al. An in-vitro study of the sterol content and toxin production of Fusarium isolates from mycotic keratitis. , 1994, Journal of medical microbiology.
[200] M. Marquart,et al. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions. , 2005, Investigative ophthalmology & visual science.
[201] M. Sanders,et al. Assessment of Streptococcus pneumoniae Capsule in Conjunctivitis and Keratitis in vivo Neuraminidase Activity Increases in Nonencapsulated Pneumococci following Conjunctival Infection , 2010, Current eye research.
[202] Tetsurou Yamamoto,et al. The role ofPseudomonas aeruginosa elastase in corneal ring abscess formation in pseudomonal keratitis , 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.
[203] E. Cohen,et al. Spectrum of Fungal Keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania , 2000, Cornea.
[204] J. Bouchara,et al. Adherence of Candida albicans germ tubes to plastic: ultrastructural and molecular studies of fibrillar adhesins , 1988, Infection and immunity.
[205] W. Mieler,et al. Voriconazole in the treatment of fungal eye infections: a review of current literature , 2008, British Journal of Ophthalmology.
[206] C. Rapuano,et al. Successful management of Burkholderia cepacia keratitis after LASIK. , 2013, Journal of refractive surgery.